William Dahms
Overview
Explore the profile of William Dahms including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Younes N, Cleary P, Steffes M, de Boer I, Molitch M, Rutledge B, et al.
Clin J Am Soc Nephrol
. 2010 May;
5(7):1235-42.
PMID: 20448066
Background And Objectives: The objective of this study was to compare random urine albumin-creatinine ratio (ACR) with timed urine albumin excretion rate (AER) in patients with type 1 diabetes. Design,...
2.
Musen G, Jacobson A, Ryan C, Cleary P, Waberski B, Weinger K, et al.
Diabetes Care
. 2009 Apr;
32(4):e46.
PMID: 19336634
No abstract available.
3.
Musen G, Jacobson A, Ryan C, Cleary P, Waberski B, Weinger K, et al.
Diabetes Care
. 2008 Jul;
31(10):1933-8.
PMID: 18606979
Objective: The purpose of this study was to evaluate whether severe hypoglycemia or intensive therapy affects cognitive performance over time in a subgroup of patients who were aged 13-19 years...
4.
Jacobson A, Musen G, Ryan C, Silvers N, Cleary P, Waberski B, et al.
N Engl J Med
. 2007 May;
356(18):1842-52.
PMID: 17476010
Background: Long-standing concern about the effects of type 1 diabetes on cognitive ability has increased with the use of therapies designed to bring glucose levels close to the nondiabetic range...
5.
Genuth S, Sun W, Cleary P, Sell D, Dahms W, Malone J, et al.
Diabetes
. 2005 Oct;
54(11):3103-11.
PMID: 16249432
Several mechanistic pathways linking hyperglycemia to diabetes complications, including glycation of proteins and formation of advanced glycation end products (AGEs), have been proposed. We investigated the hypothesis that skin collagen...
6.
Kasumov T, Brunengraber L, Comte B, Puchowicz M, Jobbins K, Thomas K, et al.
Drug Metab Dispos
. 2004 Jan;
32(1):10-9.
PMID: 14709615
Phenylbutyrate is used to treat inborn errors of ureagenesis, malignancies, cystic fibrosis, and thalassemia. High-dose phenylbutyrate therapy results in toxicity, the mechanism of which is unexplained. The known metabolites of...